| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash (used in) provided by financing activities | -6,063,778 | -5,676,899 |
| Net decrease in cash and cash equivalents | -2,767,439 | -1,876,903 |
| Cash and cash equivalents at beginning of period | 17,964,184 | - |
| Cash and cash equivalents at end of period | 15,196,745 | - |
CUMBERLAND PHARMACEUTICALS INC (CPIX)
CUMBERLAND PHARMACEUTICALS INC (CPIX)